SSX4 Protein (Transcript Variant 1) (Myc-DYKDDDDK Tag)
-
- Target See all SSX4 Proteins
- SSX4 (Synovial Sarcoma, X Breakpoint 4 (SSX4))
- Protein Type
- Recombinant
- Protein Characteristics
- Transcript Variant 1
- Origin
- Human
-
Source
- HEK-293 Cells
- Purification tag / Conjugate
- This SSX4 protein is labelled with Myc-DYKDDDDK Tag.
- Application
- Antibody Production (AbP), Standard (STD)
- Characteristics
-
- Recombinant human SSX4 (transcript variant 1) protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
- Purity
- > 80 % as determined by SDS-PAGE and Coomassie blue staining
- Top Product
- Discover our top product SSX4 Protein
-
Synovial Sarcoma, X Breakpoint 4 (SSX4) (AA 1-188) protein (GST tag)
SSX4 Origin: Human Host: Wheat germ Recombinant ELISA, WB, AP, AA
Synovial Sarcoma, X Breakpoint 4 (SSX4) (AA 1-188) protein (His-IF2DI Tag)SSX4 Origin: Human Host: Escherichia coli (E. coli) Recombinant Greater than 95 % by SDS-PAGE gel analyses ELISA, WB
Synovial Sarcoma, X Breakpoint 4 (SSX4) (AA 91-188) protein (GST tag)SSX4 Origin: Human Host: Wheat germ Recombinant ELISA, WB, AP, AA
-
- Application Notes
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays - Comment
-
The tag is located at the C-terminal.
- Restrictions
- For Research Use only
-
- Concentration
- 50 μg/mL
- Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
- Storage
- -80 °C
- Storage Comment
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
- Target
- SSX4 (Synovial Sarcoma, X Breakpoint 4 (SSX4))
- Alternative Name
- Ssx4 (SSX4 Products)
- Synonyms
- CT5.4 Protein, SSX family member 4 Protein, SSX4 Protein
- Background
- The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. Chromosome Xp11 contains a segmental duplication resulting in two identical copies of synovial sarcoma, X breakpoint 4, SSX4 and SSX4B, in tail-to-tail orientation. This gene, SSX4, represents the more telomeric copy. Two transcript variants encoding distinct isoforms have been identified for this gene.
- Molecular Weight
- 21.7 kDa
- NCBI Accession
- NP_005627
-
